
Epinote Plus 200mg/87mg Tablet CR
Marketer
Neuracle Lifesciences Pvt Ltd
Salt Composition
Sodium Valproate (200mg) + Valproic Acid (87mg)
Overview Epinote Plus 200mg/87mg Tablet CR
Combivent Duo 200mg/87mg Extended-Release tablets combine two medications to manage epilepsy, a neurological condition characterized by recurring seizures. This medication regulates abnormal brain activity, calming nerves to prevent seizures. Take Combivent Duo with food; dosage, determined by your physician, may be gradually increased until your condition stabilizes. Therapeutic effects may take weeks; consistent use is crucial. Discontinue only under medical supervision, as cessation may trigger increased seizure frequency or worsen bipolar symptoms. Common side effects include nausea and tremors; less frequent reactions might encompass vomiting, headache, hepatic impairment, and upper abdominal discomfort. Most side effects resolve spontaneously, but persistent or bothersome symptoms warrant medical attention; management strategies often exist. Prior to commencing treatment, disclose any kidney or liver issues, meningitis history, depression, or suicidal ideation to your doctor. Inform your physician about all concurrent medications, including contraceptives, as interactions are possible. While use during pregnancy or breastfeeding is possible if medically necessary, dosage adjustments may be required. Refrain from operating vehicles or bicycles if drowsiness or dizziness occurs. Regular blood tests monitor therapeutic response. Avoid alcohol consumption, as it might exacerbate side effects. Weight gain is a potential consequence; maintain a balanced diet, limit high-calorie snacks, and engage in regular physical activity. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal thoughts or actions to your doctor immediately.
Uses of Epinote Plus 200mg/87mg Tablet CR
Seizure disorder
Major Benefits of Epinote Plus 200mg/87mg Tablet CR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Epinote Plus 200mg/87mg Controlled-Release Tablets should be administered with a meal.
Common Side effects of Epinote Plus 200mg/87mg Tablet CR:
- Nausea
- Tremors
How to use Epinote Plus 200mg/87mg Tablet CR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Epinote Plus 200mg/87mg Tablet CR whole; do not alter its form by chewing, crushing, or breaking. Administer this medication with a meal.
How Epinote Plus 200mg/87mg Tablet CR works:
Epinote Plus CR tablets (200mg/87mg) contain a dual anticonvulsant formulation of valproic acid and sodium valproate.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Epinote Plus 200mg/87mg CR tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The extended-release combination tablet Epinote Plus (200mg/87mg) presents a confirmed risk to a fetus and should not be used during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Epinote Plus tablets (200mg/87mg) are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Taking Epinote Plus 200mg/87mg Controlled-Release tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
The use of Epinote Plus 200mg/87mg CR tablets in patients with kidney disease appears to be generally safe. Current evidence indicates dose modification may not be necessary, but individual cases require physician evaluation. Consult your doctor regarding your kidney health and the use of this medication.
LiverCAUTION
Patients with liver impairment should use Epinote Plus 200mg/87mg CR tablets cautiously, potentially requiring dose modification. Consult a physician for guidance. Epinote Plus 200mg/87mg CR tablets are unsuitable for individuals with severe or active liver disease.
What if you forget to take Epinote Plus 200mg/87mg Tablet CR :
Should you forget to take a dose of your Epinote Plus 200mg/87mg CR tablet, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Epinote Plus 200mg/87mg Tablet CR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
